NF2 and neoplasm: TERT_prom and NF2 mutations were significantly associated with the tumor stage (P = 0.025 and P = 0.007, respectively) and showed significant higher mutation rate in patients with stage IV tumors (20% and 28%, respectively) than in patients with stage I/III tumors (9% and 13%, respectively) (Fig. S9B).